Cognition Therapeutics, Inc. · NASDAQ:CGTX
Doyle John Brendan had 8,567 Cognition Therapeutics, Inc. shares withheld for tax (Form 4)
Traded May 1, 2026 · Filed May 4, 2026
On May 1, 2026, Doyle John Brendan (Chief Financial Officer) had 8,567 Cognition Therapeutics, Inc. shares withheld for tax at US$1.28 for US$10,966, leaving 618,942 shares. Filed May 4, 2026 (Form 4).
- Withheld for tax
- 8,567 shares
- Price
- US$1.28
- Value
- US$10,966
- Holding after
- 618,942 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Shares withheld for tax | 8,567 | US$1.28 | 618,942 | Direct |
Source
Related
- Cognition Therapeutics, Inc.
- Doyle John Brendan
- Cognition Therapeutics, Inc. shareholders
- Form 4 · Doyle John Brendan · Apr 20, 2026
- Form 4 · Khattar Jack A. · Jun 22, 2026
- Form 4 · Monia Brett P · Jun 22, 2026
- Form 4 · Wallace Peggy · Jun 22, 2026
- Form 4 · Richstone Ellen B · Jun 22, 2026
- Form 4 · BIOS Memory SPV I, LP · Jun 22, 2026